595 patents currently held
32 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
64
Ending by 2030
Dec 2026
Next term end
380
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Dec 2030 · Medium confidence
Also notable
Ends May 2032 · High confidence
Also notable
Ends Jul 2032 · High confidence
System and Method for Detection of Disconnection in an Extracorporeal Blood Circuit
US 8,535,522
Cited by 124 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Remote Control of Dialysis Machines
US 8,769,625
Cited by 144 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Sensor clip assembly for an optical monitoring system
US 9,801,993
Cited by 48 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Formerly held, still cited
Notable
Ends Dec 2028 · Medium confidence
Cited by 250 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
now held by Vantive Health GmbH
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 10 fees due Dec 6 to 27, 2026 · next Dec 6
- 11 fees due Jan 2 to 30, 2027 · next Jan 2
- 14 fees due Feb 6 to 28, 2027 · next Feb 6
- 12 fees due Mar 3 to 22, 2027 · next Mar 3
- 16 fees due Apr 1 to 24, 2027 · next Apr 1
- 12 fees due May 3 to 28, 2027 · next May 3
- 12 fees due Jun 1 to 30, 2027 · next Jun 1
- 13 fees due Jul 2 to 30, 2027 · next Jul 2
- 5 fees due Aug 4 to 25, 2027 · next Aug 4
- 9 fees due Sep 3 to 30, 2027 · next Sep 3
- 15 fees due Oct 2 to 30, 2027 · next Oct 2
- 3 fees due Nov 7 to 12, 2027 · next Nov 7
Recent changes
- 15 of the patents on this record were granted since Aug 18, 2026
- 13 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 380 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Blood Chamber for an Optical Blood Monitoring System | 11 in force | to Sep 2033 |
| Valve System | 11 in force | to Nov 2032 |
| Remote Control of Dialysis Machines | 11 in force | to May 2032 |
| Associating Dialysis Accessories Using Near Field Communication | 8 in force | to Oct 2035 |
| Medical Device Management Using Associations | 7 in force | to Mar 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,935,070 | Systems and Methods for Dextrose Containing Peritoneal Dialysis (PD) Solutions with Neutral PH and Reduced Glucose Degradation Product In force · High confidence | In force | High confidence | |
| US 10,010,686 | Fluid Control System and Disposable Assembly held by Fresenius Kabi USA, LLC In force · High confidence | In force | High confidence | |
| US 7,654,982 | Flow Control System and Method with Variable Pressure and Variable Resistance held by Fresenius Kabi USA, LLC In force · High confidence | In force | High confidence | |
| US D681,210 | Dialysis Fluid Line Carrier In force · High confidence | In force | High confidence | |
| US 7,871,391 | Extracorporeal Fluid Circuit In force · High confidence | In force | High confidence | |
| US 7,605,710 | Wetness Sensor In force · High confidence | In force | High confidence | |
| US 7,985,212 | Systems and Methods for Delivery of Peritoneal Dialysis (PD) Solutions In force · Medium confidence | In force | Medium confidence | |
| US D693,923 | Visual Aid Transducer Protector In force · High confidence | In force | High confidence | |
| US 7,837,666 | Systems and Methods for Delivery of Peritoneal Dialysis (PD) Solutions In force · High confidence | In force | High confidence | |
| US 8,067,760 | Impulse Analysis for Flow Sensor-Based Fluid Control System held by Fresenius Kabi USA, LLC In force · High confidence | In force | High confidence |
Also on record, not counted in the 595: 32 patents in force now held by others · 196 patents ended · 172 applications pending · 132 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.